Thomas Weimer

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Innovative spiral electrode configuration for enhancement of electrocoagulation-flotation.

Innovative spiral electrode configuration for enhancement of electrocoagulation-flotation.

Journal: Journal of environmental management
Published: May 30, 2023

Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.

Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.

Journal: Journal of thrombosis and haemostasis : JTH
Published: December 02, 2020

Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent.

Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent.

Journal: Blood cells, molecules & diseases
Published: November 13, 2020

FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.

FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.

Journal: Blood advances
Published: September 18, 2019

FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.

FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.

Journal: British journal of haematology
Published: October 01, 2015

The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.

The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.

Journal: PloS one
Published: September 18, 2015

Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII.

Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII.

Journal: Thrombosis research
Published: November 01, 2013

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).

Journal: Journal of thrombosis and haemostasis : JTH
Published: September 03, 2013

Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.

Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.

Journal: Thrombosis research
Published: April 08, 2013

Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin.

Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin.

Journal: Thrombosis and haemostasis
Published: March 12, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026